A European, prospective, observational study of enzalutamide in patients with metastatic castration-resistant prostate cancer: PREMISE. Payne H, Robinson A, Rappe B, Hilman S, et al. Int J Cancer 2021 Oct 14. doi: 10.1002/ijc.33845.

Read + Share

Amedeo Smart

Independent Medical Education